Dashboard
Financial statements
DHR

Company financials

Danaher Corporation

Health Care Life Sciences Tools & Services Washington, D.C. Last filing Feb 24, 2026 · FY2025
Revenue FY2025
$24.6B
3y CAGR -2.7% P10
Net income FY2025
$3.6B
Net margin +14.7% P65
Total assets FY2025
$83.5B
ROA +4.3% P37
Operating cash flow FY2025
$6.4B
FCF margin +21.4% P78
19 yrs · FY2007–FY2025 8 filed · 1 derived · 0 blank

Each cell as a share of that year’s total assets.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 10 years
Total assets $83.5B
Total liabilities ~$30.9B
Shareholders equity $52.5B
Account 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 Trend
Assets
Cash and Cash Equivalents 5.5% 2.7% 6.9% 7.1% 3.1% 7.9% 32.1% 1.6% 1.4% 2.1%
Short Term Investments 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.2% 0.3% 0.0% 0.0%
Accounts Receivable 4.7% 4.6% 4.6% 5.8% 5.6% 5.3% 5.1% 7.3% 7.5% 7.0%
Inventory 3.0% 3.0% 3.1% 3.7% 3.3% 3.0% 2.6% 4.0% 3.9% 3.8%
Prepaid Expenses 2.1% 2.0% 1.8% 2.2% 2.0% 1.9% 1.4% 1.9% 1.8% 1.8%
Other Current Assets 5.0% 5.1% 4.3% 5.3% 4.5% 3.1% 2.8% 1.4% 1.2% 1.4%
Total Current Assets 15.3% 12.2% 16.5% 18.8% 14.0% 18.1% 41.2% 14.8% 14.7% 14.7%
Property,Plant and Equipment 6.6% 6.4% 5.4% 4.4% 4.6% 4.3% 3.7% 4.7% 5.3% 5.2%
Operating Lease Assets 1.5% 1.4% 1.2% 1.2% 1.3% 1.2% 1.2%
Goodwill 51.7% 52.2% 49.2% 44.2% 49.5% 46.5% 36.6% 47.2% 53.9% 52.6%
Intangible Assets 21.3% 23.9% 24.6% 24.1% 27.5% 27.9% 15.7% 24.4% 25.0% 26.1%
Other Noncurrent Assets 5.0% 5.1% 4.3% 5.3% 4.5% 3.1% 2.8% 1.4% 1.2% 1.4%
Total Assets 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Liabilities
Accounts Payable 2.2% 2.3% 2.1% 2.7% 3.1% 2.7% 2.4% 3.6% 3.2% 3.3%
Accrued Liabilities 5.9% 5.9% 5.7% 6.5% 6.7% 7.0% 5.2% 6.4% 6.6% 6.2%
Current Portion of Long Term Debt 0.0% 0.7% 2.0% 0.7% 0.0% 0.0% 0.3% 0.1% 0.4% 5.7%
Other Current Liabilities 6.8% 7.3% 7.1% 8.0% 9.3% 10.2% 8.6% 10.6% 11.1% 12.5%
Total Current Liabilities 8.2% 8.8% 9.8% 9.9% 9.8% 9.7% 7.9% 10.1% 10.3% 15.2%
Long Term Debt 22.1% 20.0% 19.8% 22.6% 26.6% 27.8% 34.7% 20.3% 22.1% 21.4%
Other Noncurrent Liabilities 6.8% 7.3% 7.1% 8.0% 9.3% 10.2% 8.6% 10.6% 11.1% 12.5%
Equity
Preferred Stock 0.0% 0.0% 0.0% 2.0% 3.9% 4.3% 2.6% 0.0% 0.0% 0.0%
Common Stock 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Additional Paid In Capital 20.6% 21.6% 16.7% 14.3% 12.1% 12.7% 12.2% 12.2% 11.9% 11.7%
Retained Earnings 56.2% 57.0% 48.6% 46.5% 39.5% 35.7% 38.9% 52.6% 48.9% 45.7%
Treasury Stock 13.6% 10.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Accumulated Other Comprehensive Income -0.2% -4.2% -2.1% -3.4% -1.2% -0.5% -4.9% -5.8% -4.3% -6.7%
Noncontrolling Interest 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2%
Total Stockholders Equity 62.9% 63.9% 63.3% 59.4% 54.3% 52.2% 48.8% 59.0% 56.5% 50.8%
Total Liabilitiesand Equity 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 10 years
Ratio 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Profitability
Gross margin +59.1% +59.5% +58.7% +60.8% +61.4% +56.0% +55.7% +55.8% +55.2% +55.3%
Operating margin +19.1% +20.4% +21.8% +28.3% +25.7% +19.0% +18.3% +17.9% +16.6% +16.2%
Net margin +14.7% +16.3% +19.9% +27.1% +25.9% +16.4% +16.8% +15.5% +16.1% +15.1%
FCF margin +21.4% +22.2% +24.2% +27.8% +28.7% +24.3% +18.5% +20.2% +18.7% +17.4%
Growth
Revenue CAGR (3y) -2.7% -1.3% +2.3% +14.2% +13.3% +12.8% +2.0% +5.7% +6.4% -2.6%
Returns
ROE +6.9% +7.9% +8.9% +14.4% +14.2% +9.2% +9.9% +9.4% +9.5% +11.1%
ROA +4.3% +5.0% +5.6% +8.5% +7.7% +4.8% +4.8% +5.5% +5.3% +5.6%
ROIC +6.0% +6.4% +6.6% +10.5% +8.2% +6.2% +7.5% +6.7% +6.1% +6.6%
Liquidity
Current ratio 1.87x 1.40x 1.68x 1.89x 1.43x 1.86x 5.19x 1.47x 1.43x 0.97x
Quick ratio 1.25x 0.83x 1.18x 1.30x 0.89x 1.36x 4.68x 0.88x 0.87x 0.60x
Leverage
D/E 0.59x 0.57x 0.58x 0.68x 0.84x 0.92x 1.05x 0.70x 0.77x 0.97x
Interest coverage 17.70x 17.49x 18.19x 36.94x 27.61x 15.39x 30.27x 22.30x 18.36x 14.83x
Efficiency
Asset turnover 0.29x 0.31x 0.28x 0.32x 0.30x 0.29x 0.29x 0.36x 0.33x 0.37x
Cash conversion cycle +82d +76d +91d +96d +76d +75d +70d +84d +100d +80d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched
Saving notes adds DHR to your watchlist.